President Joe Biden has thrown his support to an international effort to waive drugmakers’ patent rights on the covid vaccines, but the pharmaceutical industry vows to fight back. Julie Rovner, KHN’s chief Washington correspondent, joins The Atlantic’s “Social Distance” podcast, hosted by Dr. James Hamblin and Maeve Higgins, to talk about the current patent controversy and how the drug industry has protected itself over the years with vibrant campaigns about the needs for high profits to support drug development.
Copy And Paste To Republish This Story
Listen: Exploring Controversial Efforts to Waive Drugmakers’ Vaccine Patent Rights
We encourage organizations to republish our content, free of charge. Here’s what we ask:
You must credit us as the original publisher, with a hyperlink to our khn.org site. If possible, please include the original author(s) and “Kaiser Health News” in the byline. Please preserve the hyperlinks in the story.
It’s important to note, not everything on khn.org is available for republishing. If a story is labeled “All Rights Reserved,” we cannot grant permission to republish that item.
Have questions? Let us know at KHNHelp@kff.org